Previous close | 64.50 |
Open | 64.50 |
Bid | 75.95 |
Ask | 77.40 |
Strike | 165.00 |
Expiry date | 2024-06-21 |
Day's range | 64.50 - 64.50 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Moderna (MRNA) posts data on three experimental vaccines and intends to advance them to late-stage studies. It also secures $750 million in funding from Blackstone to advance its influenza program.
Apellis Pharmaceuticals (APLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Praxis Precision Medicines, Inc. (PRAX) and Viking Therapeutics, Inc. (VKTX) gain from positive study updates.